[Academics in ophthalmology : An analysis of the gender distribution at German university hospitals and the Clinician Scientist Program].

Background: The number of female ophthalmologists has risen steadily in recent years. The aim of this study is to investigate the gender ratios, subspecialties, and academic degrees of ophthalmologists at German university hospitals. Additionally, the study analyzes the proportion of women in science programs such as the Clinician Scientist Program.

Ab interno canaloplasty (ABiC)-12-month results of a new minimally invasive glaucoma surgery (MIGS).

Purpose: The aim of this study is to assess whether the ab interno canaloplasty is a reasonable minimally invasive method to lower significantly the IOP level and number of antiglaucomatous medication over a certain period of time in adult primary open angle glaucoma (POAG).

Methods: In this retrospective cohort outcome study, 36 eyes of 28 POAG patients (mean age 74.8 ± 9.

iStent inject as a reasonable alternative procedure following failed trabeculectomy?

Purpose:: The aim of this study is to assess the intraocular pressure lowering effect and the performance of the glaucoma therapy of the iStent inject in glaucoma patients with uncontrolled intraocular pressure after failed trabeculectomy.

Methods:: In this retrospective study, iStent inject implantation (Glaukos Corporation, Laguna Hills, CA, USA) was performed in 22 eyes of 21 subjects suffering from glaucoma (n = 18 primary open angle glaucoma, n = 3 pseudoexfoliation glaucoma, and n = 1 for secondary glaucoma) with an intraocular pressure above target pressure after failed trabeculectomy (mean = 9.6 ± 8.

Contralateral eye comparison study in MICS & MIGS: Trabectome® vs. iStent inject®.

Purpose: To compare the safety and efficacy profile after combined micro-incision cataract surgery (MICS) and micro-invasive glaucoma surgery (MIGS) with the ab interno trabeculectomy (Trabectome®) in one eye versus two iStent® inject devices in the contralateral eye in patients with open-angle glaucoma (OAG) and cataract.

Methods: This retrospective, intraindividual eye comparison study included 27 patients (54 eyes) who were treated with combined MICS and ab interno trabeculectomy (group I, Trabectome®) in one eye and two iStent® inject devices (group II, GTS 400) in the fellow eye. Primary outcome measures included intraocular pressure (IOP) and glaucoma medication after 6 weeks, 3, 6, and 12 months follow-up.